NDC 70518-3965-01 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3965
- Requested NDC
- 70518-3965-01
- Package NDCs from labels
- 70518-3965-0, 70518-3965-1, 70518-3965-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-06-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-06-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3965-0 | Doxazosin | 30 in 1 BLISTER PACK | TABLET | 30 | 4 | |
| 70518-3965-1 | Doxazosin | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3965 | DOXAZOSIN TABLET [REMEDYREPACK INC.] | 3 | Current NDC, 2 package rows | 20240503_ec06f008-37a1-4757-a3ee-0b4720912bc4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | Zydus Pharmaceuticals USA Inc. | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 2023-09-16 | Warnings, Adverse reactions | ANDA208719 68382-784 197625 197628 197626 197627 92ead971-9de8-4240-b2c7-fc2e9abac7dd e4758bf9-b9d4-4268-beb8-0d7e06890895 86P6PQK0MU |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | BioActive Nutritional | 3382df85-3ec5-4371-830e-4ed345b8f51b | 2023-07-14 | Warnings | 368GB5141J |
| Pneumotox | TRITICUM AESTIVUM, ALFALFA, ARNICA MONTANA, ASCLEPIAS TUBEROSA, CHAMOMILLA, ECHINACEA (ANGUSTIFOLIA), EUCALYPTUS GLOBULUS, FUCUS VESICULOSUS, HORDEUM VULGARE, IODIUM, NASTURTIUM AQUATICUM, PLANTAGO MAJOR, RAPHANUS SATIVUS, TRIFOLIUM PRATENSE, TRIGONELLA FOENUM-GRAECUM, SYMPHYTUM OFFICINALE, LUNG (SUIS), ORYZA SATIVA, SILICEA, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, NATRUM MURIATICUM, NITRICUM ACIDUM, | BioActive Nutritional, Inc. | f8846fb1-92e5-4f8e-b3b3-bc620df90a62 | 2023-07-12 | Warnings | 368GB5141J |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Chartwell RX, LLC | a7f589b0-eebb-48cb-912f-a4bd956e4dcb | 2023-06-09 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Cardura XL | DOXAZOSIN MESYLATE | Viatris Specialty LLC | 355bcdce-0481-48ba-8ebd-2009106aaf77 | 2023-05-15 | Warnings, Adverse reactions | 86P6PQK0MU |
| Ferrum Oxydatum | FERRUM OXYDATUM | Hahnemann Laboratories, INC. | f8b52d3f-3fe2-a850-e053-6394a90a5d9f | 2023-04-06 | 1K09F3G675 | |
| Petrochemical Detox | CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SYMPHYTUM OFFICINALE, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, CADMIUM SULPHURATUM, GELSEMIUM SEMPERVIRENS, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PLATINUM METALLICUM, LATRODECTUS MACTANS | Deseret Biologicals, Inc. | b38b492a-cf45-4aa2-ba7e-4573d2c4ebe5 | 2023-01-12 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | Proficient Rx LP | 8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d | 2022-08-01 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | b364c7a8-72b5-4776-a500-400c37a72c9b | 2022-02-03 | Warnings, Adverse reactions | 197628 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Mylan Pharmaceuticals Inc. | 6b887aa5-5edf-48c5-a480-dea8c35afa9d | 2022-01-20 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Cardura | DOXAZOSIN | ROERIG | eefc47bc-c10f-49bb-8ef7-5999f798ab39 | 2022-01-20 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | f1dc70f6-4329-46da-8990-7bd6eec9d37d | 2021-12-07 | Warnings, Adverse reactions | 197628 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Teva Pharmaceuticals USA, Inc. | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 2021-11-30 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 6b74b18f-b89a-4109-a29e-c4fa65a3c5ee | 2020-12-10 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 7e547752-a53a-4ad9-b70e-7cc2a1dd5d5d | 2018-03-06 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.